InvestorsHub Logo
Followers 20
Posts 5313
Boards Moderated 0
Alias Born 01/04/2012

Re: None

Sunday, 04/25/2021 3:34:01 PM

Sunday, April 25, 2021 3:34:01 PM

Post# of 14839
Novitium received approval for Famotidine oral suspension generic on April 20th. Looks like they will be the only competition for Lupin's drug which is tracking toward $200 million in US sales (TTM)

Jefferies sees the U.S. Food and Drug Administration approval for a new generic of a heartburn drug as a negative for Lupin Ltd.

“Novitium has received FDA approval for Famotidine oral suspension generic. It is a single-source product where Lupin is the only supplier currently. By our estimates, it accounted for about 15% of Lupin’s U.S. sales in FY21”



Famotidine oral suspension generic
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News